BIOMIN are dedicated to developing innovative and sustainable solutions that ensure our customers’ success through healthy and safe animal nutrition.
The application of science and expertise is based on first understanding and appreciating our customer’s needs and concerns. This principle enables us to deliver solutions that support animal health, optimize performance and production efficiency.
BIOMIN, a leader in animal nutrition and health, develops and produces feed additives, premixes and services for the improvement of animal performance, in an economically viable way.
Our products cover solutions for mycotoxin risk management, holistic approaches towards promoting growth naturally as well as specific solutions that address dietary requirements for swine, poultry, dairy and beef cattle as well as aquaculture.
Research - at the heart of BIOMIN
Research and development is the cornerstone of all we do. All application-oriented basic research is conducted by our in-house R&D team at the BIOMIN Research Center (BRC) at Campus Tulln in Austria.
Collaborations with global institutions and organisations strengthen the BIOMIN research core. Synergies from these research collaborations inspire us to push the boundaries of animal nutrition and continue developing customer-oriented solutions that are a step ahead of the competition.
Through joint projects with universities and research institutes, BIOMIN is constantly in touch with the latest scientific knowhow, from which novel feed additives are developed and produced. We currently collaborate with over 150 institutions worldwide.
4D Pharma are pioneers in understanding and utilising the functionality of bacteria as a revolutionary new class of medicines – called live biotherapeutics.
We understand that bacteria which colonise the human body – known as the microbiome – have a key function in health and disease. More than just aiding in the digestion of food and production of vitamins; they play an important role in the regulation of our immune system. We are also forging an understanding of their role in the maintenance of our central nervous system.
These extensive interactions with the human body mean that live biotherapeutics are not just limited to the treatment of gastrointestinal conditions such as IBS and Crohn’s Disease. We have also identified bacteria that are potentially safe and efficacious therapies for diseases such as cancer, asthma, autism and autoimmune conditions such as rheumatoid arthritis and multiple sclerosis.
4D pharma’s approach has the potential to transform treatment for many patients.
Dedicated to bringing health through food to as many people as possible, Danone is a leading global food & beverage company built on four businesses: Essential Dairy and Plant-Based Products, Waters, Early Life Nutrition and Advanced Medical Nutrition.
Danone aims to inspire healthier and more sustainable eating and drinking practices, in line with its vision -Danone, One Planet. One Health- which reflects a strong belief that the health of people and the health of the planet are interconnected.
Building on health-focused categories, Danone commits to operating in an efficient and responsible manner to create and share sustainable value. Danone holds itself to the highest standards in doing business, as reflected by its ambition to become one of the first multinationals certified as B Corp. With products sold in over 120 markets, Danone generated sales of €24.7 billion in 2017.
Danone’s portfolio includes leading international brands (Activia, Actimel, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, amongst others) as well as strong local and regional brands (including AQUA, Blédina, Bonafont, Cow & Gate, Horizon Organic, Mizone, Oikos, Prostokvashino, Silk and Vega).
Listed on Euronext Paris and on the OTCQX market via an ADR (American Depositary Receipt) program, Danone is a component stock of leading social responsibility indexes including the Dow Jones Sustainability Indexes, Vigeo, the Ethibel Sustainability Index, MSCI Global Sustainability, MSCI Global SRI Indexes and the FTSE4Good Index.
Build a better future for animal nutrition.
Our mission is to provide the world with high-quality, affordable, healthy and sustainable food.
Adisseo contributes to the sustainable growth of the planet. Adisseo delivers innovative products and services to the feed industry. Adisseo is committed to a fair balance, of the value we are creating, between our customers, employees and shareholders.
Adisseo is one of the world's leading experts in feed additives
We rely on 7 research centres and two production platforms based in Europe and China to design, produce and market nutritional solutions for sustainable animal feed.
We offer our customers different forms of an essential amino acid, methionine for poultry and swine as well as protected methionine for ruminants. A complete range of vitamins, multi-activities enzymes, selenium sources and probiotics are pillars in our portfolio. Adisseo also supports the development of its customers by providing valuable and innovative services.
We embrace a policy of continuous research and innovation of our product and service offers. Our R&D Nutrition and Animal Health Department, alongside basic research, conducts numerous pioneering projects in feed digestibility, oxidative stress and digestive health. As a science-based company, Adisseo is dedicated to drive and impulse research and offers young and confirmed scientists exciting possibilities to develop their career (see our current offers here.)
Bioprocess Control is a market leader in the area of low gas flow analytical instruments for biotechnology related applications.
We invest in innovation and development of smart instruments that allow for more efficient, reliable and higher quality research and analysis, leading to significant reductions in time and labour. We ensure the highest product quality throughout our portfolio, and focus on being service minded and always meeting the needs of our customers.
NCIMB manages the UK’s National Collection of Industrial, Food and Marine Bacteria - the biggest reference collection of industrially and environmentally valuable microorganisms in the UK.
We provide specialist microbiology, chemical analysis and biomaterial storage products and services to support our customers in their research and development projects, quality control procedures, intellectual property protection and compliance with environmental regulations.
Our customers include companies in the pharmaceutical, personal care, food, oil and gas, agricultural and environmental sectors, as well as universities and research organisations around the globe.
Don Whitley Scientific Limited is a leading international supplier of innovative equipment and services to the microbiology and tissue culture industries.
We develop, manufacture, market and service instrumentation and associated products for the public and private sector - primarily for use in hospitals, public health laboratories, food testing organisations, pharmaceutical companies and research institutions.
The Microbiology Society is a membership charity for scientists interested in microbes, their effects and their practical uses. It is one of the largest microbiology societies in Europe with a worldwide membership based in universities, industry, hospitals, research institutes and schools.
Our members have a unique depth and breadth of knowledge about the discipline. The Society’s role is to help unlock and harness the potential of that knowledge.
Published by the Microbiology Society, Microbial Genomics is a fully open access, mandatory open data peer reviewed journal publishing high-profile original research on archaea, bacteria, microbial eukaryotes and viruses.
Submissions are welcome from across the breadth of microbiology and should include a genomic approach.
The International Scientific Association for Probiotics and Prebiotics (ISAPP) is a non-profit organization made up of scientists from academia and industry whose mission is to advance scientific excellence in probiotics and prebiotics.
Our activities foster the evidence-based use of probiotics and prebiotics, the advancement of scientific knowledge, and the communication of scientifically-accurate information.
Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal.